Improving medication safety and effectiveness in emergency departments using genetic testing.
Clinical Expansion of Precision Medicine in the Emergency Department
This study is looking at how using genetic testing can help doctors in emergency rooms choose the best medications for patients, making treatments safer and more effective just for you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-10993741 on NIH RePORTER |
What this research studies
This research investigates how pharmacogenetic (PGx) testing can enhance medication prescribing for patients in emergency departments. By analyzing patients' genetic profiles, the study aims to provide tailored medication recommendations that reduce adverse effects and improve treatment outcomes. The approach includes developing decision support tools for clinicians to use during patient care, ensuring that medications prescribed are more effective and safer based on individual genetic information. The research will also evaluate the economic impact of implementing PGx testing in emergency settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who are admitted to the emergency department and may require medication adjustments based on their genetic profiles.
Not a fit: Patients who do not visit emergency departments or those whose conditions do not require medication adjustments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective medication prescriptions for patients visiting emergency departments.
How similar studies have performed: Previous research has shown promising results in using pharmacogenetic testing to improve medication outcomes, indicating that this approach has potential for success.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Duarte, Julio David — University of Florida
- Study coordinator: Duarte, Julio David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.